Advertisement

Protective effects of resveratrol on hepatic ischemia reperfusion injury in streptozotocin-induced diabetic rats

  • Hanife Serife AktaşEmail author
  • Yahya Ozel
  • Sarfraz AhmadEmail author
  • Halime Hanim Pençe
  • Betul Ayaz-Adakul
  • Ilyas Kudas
  • Sermin Tetik
  • Turgut Şekerler
  • Ceren Canbey-Göret
  • Levent Kabasakal
  • Hatice Kubra Elcioglu
Article
  • 59 Downloads

Abstract

Resveratrol (RSV) is a natural polyphenolic compound having antioxidant effects. This study was designed to investigate the protective effects of resveratrol against oxidative stress in hepatic ischemia–reperfusion (I/R) injury in streptozotocin (STZ)-induced diabetic rats. STZ was injected intraperitonally (i.p.) to 18 Sprague–Dawley albino rats, which were divided into three groups, each having six rats. First group was non-treated diabetic group (D), second diabetic group was subjected to 30 min of hepatic ischemia followed by a 45-min reperfusion period (D + I/R), and third diabetic group was subjected to 30 min of hepatic ischemia followed by a 45-min reperfusion period and treated with 20 mg/kg/day oral RSV before 30 min I/R injury (D + I/R + RSV). At the end of the experimental period, animals were decapitated, and blood samples were collected to determine tissue tumor necrosis factor-α (TNF-α) levels. Liver and lung tissue samples were obtained for the evaluation of biochemical parameters including malondialdehyde (MDA) and glutathione (GSH) levels and histopathological examinations. Compared to control, I/R injury resulted in decreases in GSH levels and increases in MDA levels. Tissue TNF-α levels were also increased in the D + I/R group compared to D group. Treatment with RSV prevented the alterations on biochemical parameters and histopathological changes induced by I/R. We demonstrate that in diabetic rats, hepatic I/R injury is associated with an augmented inflammatory response and oxidative stress, while RSV pre-treatment significantly decreased these responses. Larger clinical studies are desirable to determine the exact role(s) of RSV on hepatic I/R injury among diabetic subjects.

Keywords

Resveratrol Diabetes Ischemia reperfusion injury Inflammation Experimental rats 

Notes

Funding

This study was not funded from any source, except the primary institutional support.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest associated with this research manuscript.

Ethical approval

All procedures performed in this study involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

References

  1. 1.
    American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1):S67–S74CrossRefGoogle Scholar
  2. 2.
    Yazgan ÜC, Taşdemir E, Bilgin HM, Deniz Obay B, Şermet A, Elbey B (2015) Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes. Arch Physiol Biochem 121:157–161CrossRefGoogle Scholar
  3. 3.
    Rochette L, Zeller M, Cottin Y, Vergely C (2014) Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta 1840:2709–2729CrossRefGoogle Scholar
  4. 4.
    Schmatz R, Perreira LB, Stefanello N et al (2012) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94:374–383CrossRefGoogle Scholar
  5. 5.
    Pektaş MB, Sadi G, Koca HB et al (2016) Resveratrol ameliorates the components of hepatic inflammation and apoptosis in a rat model of streptozotocin-induced diabetes. Drug Dev Res 77:12–19CrossRefGoogle Scholar
  6. 6.
    Prabhakar O (2013) Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 386:705–710CrossRefGoogle Scholar
  7. 7.
    Moridi H, Karimi J, Sheikh N et al (2015) Resveratrol-dependent down-regulation of receptor for advanced glycation end-products and oxidative stress in kidney of rats with diabetes. Int J Endocrinol Metab 20(13):e23542Google Scholar
  8. 8.
    Gedik E, Girgin S, Ozturk H, Obay BD, Ozturk H, Buyukbayram H (2008) Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J Gastroenterol 14:7101–7106CrossRefGoogle Scholar
  9. 9.
    Dünschede F, Erbes K, Kircher A et al (2006) Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by alpha-lipoic acid in humans. World J Gastroenterol 12:6812–6817CrossRefGoogle Scholar
  10. 10.
    Liu B, Qian JM (2015) Cytoprotective role of heme oxygenase-1 in liver ischemia reperfusion injury. Int J Clin Exp Med 8:19867–19873Google Scholar
  11. 11.
    Yonamine CY, Pinheiro-Machado E, Michalani ML et al (2016) Resveratrol improves glycemic control in insulin treated diabetic rats: participation of thehepatic territory. Nutr Metab (Lond) 13:44.  https://doi.org/10.1186/s12986-016-0103-0 CrossRefGoogle Scholar
  12. 12.
    Malhotra A, Bath S, Elbarbry F (2015) An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol. Oxid Med Cell Longev 2015:803971.  https://doi.org/10.1155/2015/803971 CrossRefGoogle Scholar
  13. 13.
    Oya S, Nur A, Gül G (2008) Resveratrol and cardiovascular system. Turk J Biochem 33:117–121Google Scholar
  14. 14.
    Beuge JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–311CrossRefGoogle Scholar
  15. 15.
    Beutler E (1975) Glutathione in red blood cell metabolism. A manual of biochemical methods. Grune and Stratton, New York, pp 112–114Google Scholar
  16. 16.
    Qin Y, Li Z, Wang Z et al (2014) Ghrelin contributes to protection of hepatocellular injury induced by ischaemia/reperfusion. Liver Int 34:567–575CrossRefGoogle Scholar
  17. 17.
    Rossetti A, Togliatto G, Rolo AP et al (2017) Unacylated ghrelin prevents mitochondrial dysfunction in a model of ischemia/reperfusion liverinjury. Cell Death Discov 3:17077.  https://doi.org/10.1038/cddiscovery.2017.77 CrossRefGoogle Scholar
  18. 18.
    Liu Z, Zhang X, Xiao Q et al (2017) Pretreatment donors after circulatory death with simvastatin alleviates liver ischemia reperfusion injury through a KLF2-dependent mechanism in rat. Oxid Med Cell Longev 2017:3861914.  https://doi.org/10.1155/2017/3861914 Google Scholar
  19. 19.
    Chang C, Zhao Y, Song G, She K (2018) Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats. J Neuroimmunol 315:9–14CrossRefGoogle Scholar
  20. 20.
    Erkasap S, Erkasap N, Bradford B (2017) The effect of leptin and resveratrol on JAK/STAT pathways and Sirt-1 gene expression in the renal tissue of ischemia/reperfusion induced rats. Bratisl Lek Listy 118:443–448Google Scholar
  21. 21.
    Seong H, Ryu J, Yoo WS et al (2017) Resveratrol ameliorates retinal ischemia/reperfusion injury in C57BL/6 J mice via downregulation of caspase-3. Curr Eye Res 42:1650–1658CrossRefGoogle Scholar
  22. 22.
    Yildiz F, Terzi A, Coban S et al (2009) Protective effects of resveratrol on small intestines against intestinal ischemia-reperfusion injury in rats. J Gastroenterol Hepatol 24:1781–1785CrossRefGoogle Scholar
  23. 23.
    Shimizu K, Miyagi S, Miyazawa K et al (2016) Resveratrol prevents warm ischemia-reperfusion injury in liver grafts from non-heart-beating donor rats. Transplant Proc 48:1221–1225CrossRefGoogle Scholar
  24. 24.
    He D, Guo Z, Pu JL et al (2016) Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κ B signaling pathway in vitro and in vivo. Int Immunopharmacol 35:201–209CrossRefGoogle Scholar
  25. 25.
    Sehirli O, Sener E, Cetinel S, Yuksel M, Gedik N, Sener G (2008) α-Lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol 35:249–255CrossRefGoogle Scholar
  26. 26.
    Bradamante S, Barenghi L, Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22:169–188CrossRefGoogle Scholar
  27. 27.
    Leonard SS, Xia C, Jiang BH et al (2003) Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309:1017–1026CrossRefGoogle Scholar
  28. 28.
    Chi KK, Zhang WH, Chen Z et al (2016) Comparison of quercetin and resveratrol in the prevention of injury due to testicular torsion/detorsion in rats. Asian J Androl 18:908–912Google Scholar
  29. 29.
    Cheng L, Jin Z, Zhao R, Ren K, Deng C, Yu S (2015) Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int J Clin Exp Med 8:10420–10428Google Scholar
  30. 30.
    Kirimlioglu H, Ecevit A, Yilmaz S, Kirimlioglu V, Karabulut AB (2008) Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy. Transplant Proc 40:285–289CrossRefGoogle Scholar
  31. 31.
    Kato M, Sawada T, Kita J, Shimoda M, Kubota K (2010) Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver. World J Gastroenterol 16:4838–4845CrossRefGoogle Scholar
  32. 32.
    Tao X, Sun X, Xu L (2016) Total flavonoids from rosa laevigata michx fruit ameliorates hepatic ischemia/reperfusion injury through inhibition of oxidative stress and inflammation in rats. Nutrients 8:418.  https://doi.org/10.3390/nu8070418 CrossRefGoogle Scholar
  33. 33.
    Fang L, Gao H, Zhang W, Zhang W, Wang Y (2015) Resveratrol alleviates nerve injury after cerebral ischemia and reperfusion in mice by inhibiting inflammation and apoptosis. Int J Clin Exp Med 8:3219–3226Google Scholar
  34. 34.
    Thirunavukkarasu M, Penumathsa SV, Koneru S (2007) Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43:720–729CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Hanife Serife Aktaş
    • 1
    Email author
  • Yahya Ozel
    • 2
  • Sarfraz Ahmad
    • 3
    Email author
  • Halime Hanim Pençe
    • 4
  • Betul Ayaz-Adakul
    • 5
  • Ilyas Kudas
    • 2
  • Sermin Tetik
    • 6
  • Turgut Şekerler
    • 6
  • Ceren Canbey-Göret
    • 7
  • Levent Kabasakal
    • 5
  • Hatice Kubra Elcioglu
    • 5
  1. 1.Internal Medicine ClinicUmraniye Research and Training HospitalIstanbulTurkey
  2. 2.General Surgery ClinicUmraniye Research and Training HospitalIstanbulTurkey
  3. 3.AdventHealth Medical CenterOrlandoUSA
  4. 4.Department of Biochemistry, Faculty of MedicineHealth Sciences UniversityIstanbulTurkey
  5. 5.Department of Pharmacology, Pharmacy FacultyMarmara UniversityIstanbulTurkey
  6. 6.Department of Biochemistry, Pharmacy FacultyMarmara UniversityIstanbulTurkey
  7. 7.Department of PathologyProf. Dr İlhan Varank Sancaktepe Research and Training HospitalIstanbulTurkey

Personalised recommendations